ArticleJournal of hepato-biliary-pancreatic sciences2025
The safety and feasibility of robotic pancreaticoduodenectomy: A multicenter retrospective assessment of 425 patients in Japan.
Article in Journal of hepato-biliary-pancreatic sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Article
- Evaluation of safety and efficacy of robotic-assisted pancreaticoduodenectomy (SWARS study): a study protocol for a multi-center randomized phase-2 trial.BMC surgery · 2026Article
- Novel methods for robotic pancreaticojejunostomy: stapler closure of branched pancreatic duct and local staples removal to prevent postoperative pancreatic fistula during robotic pancreaticoduodenectomy.Surgical endoscopy · 2025Article
- Article
- Navigating the Intricacies of Robotic Pylorus-Preserving Pancreaticoduodenectomy Using the da Vinci SP (Single Port) System.Journal of clinical medicine · 2025Article
- The safety and feasibility of robotic pancreaticoduodenectomy: A multicenter retrospective assessment of 425 patients in Japan.Journal of hepato-biliary-pancreatic sciences · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
21 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
background/purposeThe Japanese public health insurance system has recently covered robotic pancreaticoduodenectomy (RPD). This study aimed to review the results of RPD during the introductory period and elucidate its safety and feasibility in Japan.
methodsConsecutive data of 425 patients who underwent RPD were retrospectively collected from 10 high-volume centers in Japan between April 2020 and September 2022. The primary endpoints were the rates of conversion to open surgery and completion of minimally invasive surgery (MIS), defined as the use of a totally robotic operation or combined robotic and laparoscopic procedures. Secondary endpoints were operative time, blood loss, complication rate, and 30- and 90-day mortality rates.
resultsStudy comprised 222 males and 203 females, with a median age of 70 (p10-p90; 50-81) years. The conversion to open surgery and completion rates of MIS were 3.8% (16 patients) and 91.1% (387 patients), respectively. The median operative time was 617 min (p10-p90; 456-834 min), and the median volume of blood loss was 160 g (p10-p90; 30-558 g). The complication rate (Clavien-Dindo classification grade ≥ IIIa) was 20.5%. The 30- and 90-day mortality rates were 0.2% and 0.5%, respectively.
conclusionsOur results indicate that RPD can be introduced successfully and is a promising approach for pancreaticoduodenectomy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.